Author

Elisabeth Porter

Purdue University West Lafayette

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Amber L. MosleyiD· 1 shared Brittany L. Allen-PeterseniD· 1 shared Brittany N. HeiliD· 1 shared Claire M. PfefferiD· 1 shared Elizabeth G. HoffmaniD· 1 shared Ella Rose D. ChianisiD· 1 shared Emily G. Smith· 1 shared Emma F. KayiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amber L. MosleyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Activation of PP2A-B56α leads to aberrant EGFR signaling and proliferative phenotypes in PDAC

Claire M. Pfeffer, Sydney J. Clifford, Saadia A. Karim, Ella Rose D. Chianis, Brittany N. Heil, Lauren E. Gartenhaus, Emma F. Kay, Garima Baral, Elizabeth G. Hoffman, Sagar M. Utturkar, Harish Kothandaraman, Whitney R. Smith-Kinnaman, Kasi Hansen, Emily G. Smith, Elisabeth Porter, , Brittany L. Allen-Petersen

This study shows that activating PP2A-B56 in PDAC increases EGFR signaling and promotes tumor growth, suggesting a new therapeutic target.

bioRxiv · Jul 18, 2025 · PreprintCancer Biology